This first industry partnership represents the culmination of the last four years of work and research by the Allen Institute for Immunology. The important collaboration points to the future trajectory of the Institute’s ongoing efforts to better understand the contours of the human immune system in both health and disease: industry collaborations aimed at translating foundational insight and cutting-edge analysis tools into new treatments and therapies for disease.

It underscores the importance of foundational, basic science in advancing medicine for society and highlights the potential of the Institute’s research pipelines, tools, and resources for others in the field.

About the Allen Institute for Immunology
The Allen Institute for Immunology is a division of the Allen Institute, an independent, 501(c)(3) nonprofit medical research organization, and is dedicated to understanding the dynamic balancing act of the human immune system in health and disease. The Allen Institute for Immunology will advance our fundamental understanding of the human immune system and will identify new therapeutic avenues for disease by employing a multi-disciplinary team approach in collaboration with leading research organizations, generating novel insights about cellular and molecular drivers of immune health and immune-related diseases. The Allen Institute for Immunology will be launched in 2018 with a contribution from founder and philanthropist, the late Paul G. Allen. The data and tools generated by the Allen Institute for Immunology will be publicly available online. For more information visit immunology.alleninstitute.org.